Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo
Open Access
- 28 December 2009
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 207 (1) , 173-187
- https://doi.org/10.1084/jem.20091873
Abstract
Autoreactive B lymphocytes first encountering self-antigens in peripheral tissues are normally regulated by induction of anergy or apoptosis. According to the “two-signal” model, antigen recognition alone should render B cells tolerant unless T cell help or inflammatory signals such as lipopolysaccharide are provided. However, no such signals seem necessary for responses to T-independent type 2 (TI-2) antigens, which are multimeric antigens lacking T cell epitopes and Toll-like receptor ligands. How then do mature B cells avoid making a TI-2–like response to multimeric self-antigens? We present evidence that TI-2 antigens decorated with ligands of inhibitory sialic acid–binding Ig-like lectins (siglecs) are poorly immunogenic and can induce tolerance to subsequent challenge with immunogenic antigen. Two siglecs, CD22 and Siglec-G, contributed to tolerance induction, preventing plasma cell differentiation or survival. Although mutations in CD22 and its signaling machinery have been associated with dysregulated B cell development and autoantibody production, previous analyses failed to identify a tolerance defect in antigen-specific mutant B cells. Our results support a role for siglecs in B cell self-/nonself-discrimination, namely suppressing responses to self-associated antigens while permitting rapid “missing self”–responses to unsialylated multimeric antigens. The results suggest use of siglec ligand antigen constructs as an approach for inducing tolerance.Keywords
This publication has 82 references indexed in Scilit:
- Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5The Journal of Experimental Medicine, 2009
- Sialylated multivalent antigens engage CD22in transand inhibit B cell activationProceedings of the National Academy of Sciences, 2009
- B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esteraseThe Journal of Experimental Medicine, 2008
- Negative signaling by inhibitory receptors: the NK cell paradigmImmunological Reviews, 2008
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- Cis interactions of immunoreceptors with MHC and non-MHC ligandsNature Reviews Immunology, 2008
- CD22: an inhibitory enigmaImmunology, 2008
- Siglecs and their roles in the immune systemNature Reviews Immunology, 2007
- Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor SignalingScience, 2006
- Two categories of mammalian galactose-binding receptors distinguished by glycan array profilingGlycobiology, 2006